PHRX (Pharmagen) Long-Term Debt: $0.52 Mil (As of Mar. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmagen Long-Term Debt?

Pharmagen PHRX -90.00% Long-Term Debt is $0.52 Mil as of Mar. 2014.

Pharmagen's Long-Term Debt for the quarter that ended in Mar. 2014 was $0.52 Mil.

Pharmagen's quarterly Long-Term Debt declined from Sep. 2013 ($0.75 Mil) to Dec. 2013 ($0.50 Mil) but then increased from Dec. 2013 ($0.50 Mil) to Mar. 2014 ($0.52 Mil).

Pharmagen's annual Long-Term Debt increased from Jun. 2011 ($0.00 Mil) to Dec. 2012 ($1.25 Mil) but then declined from Dec. 2012 ($1.25 Mil) to Dec. 2013 ($0.50 Mil).

Pharmagen  (OTCPK:PHRX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pharmagen Long-Term Debt Related Terms

Pharmagen Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Pharmagen's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen Long-Term Debt Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
Long-Term Debt
0.00 0.00 1.25 0.50

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 0.75 0.75 0.50 0.52
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.52 Mil mean?
Pharmagen (PHRX) has a Long-Term Debt of $0.52 Mil as of Mar. 2014.
Is Pharmagen's Long-Term Debt too high?
Pharmagen's current Long-Term Debt is $0.52 Mil.
How does Pharmagen's Long-Term Debt compare to FZMD and SNYR?
Pharmagen's Long-Term Debt of $0.52 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Pharmagen's current Long-Term Debt is $0.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current Long-Term Debt of $0.52 Mil. The current Long-Term Debt is $0.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Pharmagen (PHRX), the current Long-Term Debt is $0.52 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.